Sorafenib in liver cancer

Author： Woo Hyun Young   Heo Jeong  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.7, 2012-05, pp. : 1059-1067

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sorafenib: In Advanced Renal Cancer

By McKeage Kate   Wagstaff Antona J.  

Drugs, Vol. 67, Iss. 3, 2007-01 ,pp. : 475-483

Adis International

Access to resources Recommend Favorite

Sorafenib for the treatment of renal cancer

By Strumberg Dirk  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. : 407-419

Informa Healthcare

Access to resources Recommend Favorite

Sorafenib for ovarian cancer

By Leone Roberti Maggiore Umberto   Valenzano Menada Mario   Venturini Pier Luigi   Ferrero Simone  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 8, 2013-08 ,pp. : 1049-1062

Informa Healthcare

Access to resources Recommend Favorite

An investigation of the effect of sorafenib on tumour growth and recurrence after liver cancer resection in nude mice independent of phosphorylated extracellular signal-regulated kinase levels

By Wang Zheng   Hu Jie   Qiu Shuang-Jian   Huang Xiao-Wu   Dai Zhi   Tan Chang-Jun   Zhou Jian   Fan Jia  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 8, 2011-08 ,pp. : 1039-1045

Informa Healthcare

Access to resources Recommend Favorite

Sorafenib enhances HRQOL in renal cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 533, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite